Trial Profile
Clinical Study to Generate Exploratory Training Set of Data on the Time Course of Gene Expression Profile at Site of Antigen Deposition Compared With Whole Blood Following IM Injection With Alum or MF59-adjuvanted Protein Subunit Vaccines
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; Influenza virus vaccine (Primary)
- Indications Hepatitis B; Influenza virus infections
- Focus Therapeutic Use
- 07 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 08 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 27 Feb 2015 New trial record